For: | Chan HLY, Wong ML, Hui AY, Chim AML, Tse AML, Hung LCT, Chan FKL, Sung JJY. Hepatitis B virus genotype has no impact on hepatitis B e antigen seroconversion after lamivudine treatment. World J Gastroenterol 2003; 9(12): 2695-2697 [PMID: 14669315 DOI: 10.3748/wjg.v9.i12.2695] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v9/i12/2695.htm |
Number | Citing Articles |
1 |
Chun-Jen Liu, Jia-Horng Kao. Hepatitis B virus genotype: What should the clinician know?. Current Hepatitis Reports 2007; 6(1): 17 doi: 10.1007/BF02942174
|
2 |
Darmadi Darmadi, Dharma Lindarto, Jelita Siregar, Tri Widyawati, Muhammad Rusda, Mustafa Mahmud Amin, Fauzi Yusuf, Putri Chairani Eyanoer, Masrul Lubis, Imelda Rey. Factors affecting HBV DNA suppression in chronic hepatitis B patients treated with tenofovir disoproxil fumarate. F1000Research 2022; 11: 1521 doi: 10.12688/f1000research.128116.1
|
3 |
Yanni YN Lui, Henry LY Chan. Treatment of chronic hepatitis B: focus on telbivudine. Expert Review of Anti-infective Therapy 2009; 7(3): 259 doi: 10.1586/eri.09.6
|
4 |
Hsin-Yun Sun, Wang-Huei Sheng, Mao-Song Tsai, Kuan-Yeh Lee, Sui-Yuan Chang, Chien-Ching Hung. Hepatitis B virus coinfection in human immunodeficiency virus-infected patients: A review. World Journal of Gastroenterology 2014; 20(40): 14598-14614 doi: 10.3748/wjg.v20.i40.14598
|
5 |
Yajun Song, Erhei Dai, Jin Wang, Hengjun Liu, Junhui Zhai, Cuiying Chen, Zongmin Du, Zhaobiao Guo, Ruifu Yang. Genotyping of hepatitis B virus (HBV) by oligonucleotides microarray. Molecular and Cellular Probes 2006; 20(2): 121 doi: 10.1016/j.mcp.2005.11.004
|
6 |
V. Jackson, W. Ferguson, T. B. Kelleher, M. Lawless, M. Eogan, U. Nusgen, S. Coughlan, J. Connell, J. S. Lambert. Lamivudine treatment and outcome in pregnant women with high hepatitis B viral loads. European Journal of Clinical Microbiology & Infectious Diseases 2015; 34(3): 619 doi: 10.1007/s10096-014-2270-0
|
7 |
Guo-Bing Zeng, Shu-Juan Wen, Zhan-Hui Wang, Li Yan, Jian Sun, Jin-Lin Hou. A novel hepatitis B virus genotyping system by using restriction fragment length polymorphism patterns of <italic>S</italic> gene amplicons. World Journal of Gastroenterology 2004; 10(21): 3132-3136 doi: 10.3748/wjg.v10.i21.3132
|
8 |
Atsushi Ono, Fumitaka Suzuki, Yusuke Kawamura, Hitomi Sezaki, Tetsuya Hosaka, Norio Akuta, Masahiro Kobayashi, Yoshiyuki Suzuki, Satoshi Saitou, Yasuji Arase, Kenji Ikeda, Mariko Kobayashi, Sachiyo Watahiki, Rie Mineta, Hiromitsu Kumada. Long-term continuous entecavir therapy in nucleos(t)ide-naïve chronic hepatitis B patients. Journal of Hepatology 2012; 57(3): 508 doi: 10.1016/j.jhep.2012.04.037
|
9 |
Johannes Wiegand, Dirk Hasenclever, Hans L Tillmann. Should Treatment of Hepatitis B Depend on Hepatitis B virus Genotypes? A Hypothesis Generated from an Explorative Analysis of Published Evidence. Antiviral Therapy 2008; 13(2): 211 doi: 10.1177/135965350801300217
|
10 |
Jia-Horng Kao. Role of viral factors in the natural course and therapy of chronic hepatitis B. Hepatology International 2007; 1(4): 415 doi: 10.1007/s12072-007-9033-2
|
11 |
Grace L.-H. Wong, Henry L.-Y. Chan. Predictors of Treatment Response in Chronic Hepatitis B. Drugs 2009; 69(16): 2167 doi: 10.2165/11319850-000000000-00000
|
12 |
Fuat Kurbanov, Yasuhito Tanaka, Masashi Mizokami. Geographical and genetic diversity of the human hepatitis B virus. Hepatology Research 2010; 40(1): 14 doi: 10.1111/j.1872-034X.2009.00601.x
|
13 |
Vincent Wai‐Sun Wong, Henry Lik‐Yuen Chan. Severe acute exacerbation of chronic hepatitis B: A unique presentation of a common disease. Journal of Gastroenterology and Hepatology 2009; 24(7): 1179 doi: 10.1111/j.1440-1746.2009.05924.x
|
14 |
Sheng Shen, Xieer Liang, Kamal Hamed, Yasuhito Tanaka, Katsumi Omagari, Rong Fan, Qing Xie, Deming Tan, Bin Zhou, Ji‐Dong Jia, Jinlin Hou, Jian Sun. Effect of hepatitis B virus subgenotype on antiviral response in nucleoside‐treated hepatitis B envelope antigen‐positive patients. Hepatology Research 2018; 48(2): 134 doi: 10.1111/hepr.12907
|
15 |
W. G. E. Cooksley. Do we need to determine viral genotype in treating chronic hepatitis B?. Journal of Viral Hepatitis 2010; : no doi: 10.1111/j.1365-2893.2010.01326.x
|
16 |
Jenny L. Limquiaco, John Wong, Vincent W.S. Wong, Grace L.H. Wong, Chi‐Hang Tse, Hoi‐Yun Chan, Katherine Y.Y. Kwan, Paul B.S. Lai, Henry L.Y. Chan. Lamivudine monoprophylaxis and adefovir salvage for liver transplantation in chronic hepatitis B: A seven‐year follow‐up study. Journal of Medical Virology 2009; 81(2): 224 doi: 10.1002/jmv.21369
|
17 |
Chih-Lin Lin, Jia-Horng Kao. Hepatitis B viral factors and treatment responses in chronic hepatitis B. Journal of the Formosan Medical Association 2013; 112(6): 302 doi: 10.1016/j.jfma.2013.02.001
|
18 |
Chun‐Jen Liu, Jia‐Horng Kao, Ding‐Shinn Chen. Therapeutic implications of hepatitis B virus genotypes. Liver International 2005; 25(6): 1097 doi: 10.1111/j.1478-3231.2005.01177.x
|
19 |
Ferruccio Bonino, Teerha Piratvisuth, Maurizia R Brunetto, Yun-Fan Liaw. Diagnostic Markers of Chronic Hepatitis B Infection and Disease. Antiviral Therapy 2010; 15(3_suppl): 35 doi: 10.3851/IMP1622
|
20 |
Chia-Ming Chu, Yun-Fan Liaw. Genotype C hepatitis B virus infection is associated with a higher risk of reactivation of hepatitis B and progression to cirrhosis than genotype B: A longitudinal study of hepatitis B e antigen-positive patients with normal aminotransferase levels at baseline. Journal of Hepatology 2005; 43(3): 411 doi: 10.1016/j.jhep.2005.03.018
|
21 |
Grace Lai-Hung Wong, Henry Lik-Yuen Chan. Molecular virology in chronic hepatitis B: genotypes. British Journal of Hospital Medicine 2005; 66(1): 13 doi: 10.12968/hmed.2005.66.1.17529
|
22 |
Yanni YN Lui, Henry LY Chan. A review of telbivudine for the management of chronic hepatitis B virus infection. Expert Opinion on Drug Metabolism & Toxicology 2008; 4(10): 1351 doi: 10.1517/17425255.4.10.1351
|
23 |
Byung-Ho Choe. The management and treatment of chronic hepatitis B in Korean children. Korean Journal of Pediatrics 2007; 50(9): 823 doi: 10.3345/kjp.2007.50.9.823
|
24 |
Chih‐Lin Lin, Jia‐Horng Kao. The clinical implications of hepatitis B virus genotype: Recent advances. Journal of Gastroenterology and Hepatology 2011; 26(s1): 123 doi: 10.1111/j.1440-1746.2010.06541.x
|
25 |
Chun-Jen Liu, Jia-Horng Kao. Genetic Variability of Hepatitis B virus and Response to Antiviral Therapy. Antiviral Therapy 2008; 13(5): 613 doi: 10.1177/135965350801300501
|
26 |
Emilio Palumbo. Hepatitis B Genotypes and Response to Antiviral Therapy: A Review. American Journal of Therapeutics 2007; 14(3): 306 doi: 10.1097/01.pap.0000249927.67907.eb
|
27 |
Zhanhui Wang, Yuehua Huang, Shujuan Wen, Bin Zhou, Jinlin Hou. Hepatitis B virus genotypes and subgenotypes in China. Hepatology Research 2007; 37(s1) doi: 10.1111/j.1872-034X.2007.00102.x
|
28 |
Chih-Lin Lin, Jia-Horng Kao. Hepatitis B Virus Genotypes: Clinical Relevance and Therapeutic Implications. Current Hepatitis Reports 2013; 12(2): 124 doi: 10.1007/s11901-013-0166-6
|
29 |
Tai‐Chung Tseng, Chun‐Jen Liu, Chia‐Chi Wang, Pei‐Jer Chen, Ming‐Yang Lai, Jia‐Horng Kao, Ding‐Shinn Chen. A higher alanine aminotransferase level correlates with earlier hepatitis B e antigen seroconversion in lamivudine‐treated chronic hepatitis B patients. Liver International 2008; 28(7): 1034 doi: 10.1111/j.1478-3231.2008.01766.x
|
30 |
Mariko Kobayashi, Fumitaka Suzuki, Norio Akuta, Yoshiyuki Suzuki, Yasuji Arase, Kenji Ikeda, Tetsuya Hosaka, Hitomi Sezaki, Masahiro Kobayashi, Satomi Iwasaki, Junko Sato, Sachiyo Watahiki, Yuzo Miyakawa, Hiromitsu Kumada. Response to long‐term lamivudine treatment in patients infected with hepatitis B virus genotypes A, B, and C. Journal of Medical Virology 2006; 78(10): 1276 doi: 10.1002/jmv.20701
|
31 |
Emma C Thomson, Janice Main. Advances in hepatitis B and C. Current Opinion in Infectious Diseases 2004; 17(5): 449 doi: 10.1097/00001432-200410000-00010
|
32 |
Angeline Oi-Shan Lo, Grace Lai-Hung Wong. Current developments in nucleoside/nucleotide analogues for hepatitis B. Expert Review of Gastroenterology & Hepatology 2014; 8(6): 607 doi: 10.1586/17474124.2014.909724
|
33 |
Sang Hoon Ahn, Henry L. Y. Chan, Pei-Jer Chen, Jun Cheng, Mahesh K. Goenka, Jinlin Hou, Seng Gee Lim, Masao Omata, Teerha Piratvisuth, Qing Xie, Hyung Joon Yim, Man-Fung Yuen. Chronic hepatitis B: whom to treat and for how long? Propositions, challenges, and future directions. Hepatology International 2010; 4(1): 386 doi: 10.1007/s12072-010-9163-9
|
34 |
Yue-Meng Wan, Yu-Hua Li, Zhi-Yuan Xu, Hua-Mei Wu, Xi-Nan Wu, Ying Xu. Genotype Matters in Patients with Acuteon-chronic Liver Failure Due to Reactivation of Chronic Hepatitis B. Clinical and Translational Gastroenterology 2018; 9(11): e202 doi: 10.1038/s41424-018-0071-y
|
35 |
H. L.‐Y. CHAN, A. M.‐L. TSE, M.‐D. ZHANG, V. W.‐S. WONG, A. M.‐L. CHIM, A. Y. HUI, J. J.‐Y. SUNG. Genetic polymorphisms of interleukin‐1‐beta in association with sustained response to anti‐viral treatment in chronic hepatitis B in Chinese. Alimentary Pharmacology & Therapeutics 2006; 23(12): 1703 doi: 10.1111/j.1365-2036.2006.02948.x
|
36 |
Chia‐Yen Dai, Ming‐Lung Yu, Ming‐Yen Hsieh, LI‐Po Lee, Nai‐Jen Hou, Jee‐Fu Huang, Shinn‐Cherng Chen, Zu‐Yau Lin, Ming‐Yuh Hsieh, Liang‐Yen Wang, Jun‐Fa Tsai, Wen‐Yu Chang, Wan‐Long Chuang. Early response to lamivudine therapy in clinically non‐cirrhotic chronic hepatitis B patients with decompensation. Liver International 2007; 27(10): 1364 doi: 10.1111/j.1478-3231.2007.01565.x
|
37 |
Philippe J. Zamor, Ashley M. Lane. Interpretation of HBV Serologies. Clinics in Liver Disease 2021; 25(4): 689 doi: 10.1016/j.cld.2021.06.012
|
38 |
Chih-Lin Lin, Jia-Horng Kao. Recent advances in the treatment of chronic hepatitis B. Expert Opinion on Pharmacotherapy 2011; 12(13): 2025 doi: 10.1517/14656566.2011.590474
|
39 |
Neil Rajoriya, Christophe Combet, Fabien Zoulim, Harry L.A. Janssen. How viral genetic variants and genotypes influence disease and treatment outcome of chronic hepatitis B. Time for an individualised approach?. Journal of Hepatology 2017; 67(6): 1281 doi: 10.1016/j.jhep.2017.07.011
|
40 |
Henry Lik-Yuen Chan, Vincent Wai-Sun Wong, Alex Yui Hui, Steven Woon-Choy Tsang, Joyce Lai-Yee Chan, Hoi-Yun Chan, Grace Lai-Hung Wong, Joseph Jao-Yiu Sung. Long-Term Lamivudine Treatment is Associated with a Good Maintained Response in Severe Acute Exacerbation of Chronic Hbeag-Negative Hepatitis B. Antiviral Therapy 2006; 11(4): 465 doi: 10.1177/135965350601100404
|
41 |
Maureen M. Jonas. Treatment of Chronic Hepatitis B in Children. Journal of Pediatric Gastroenterology and Nutrition 2006; 43(S1) doi: 10.1097/01.mpg.0000226391.02355.1b
|
42 |
Scott A. Elisofon, Maureen M. Jonas. Hepatitis B and C in Children: Current Treatment and Future Strategies. Clinics in Liver Disease 2006; 10(1): 133 doi: 10.1016/j.cld.2005.10.005
|
43 |
Maryam Moini, Scott Fung. HBsAg Loss as a Treatment Endpoint for Chronic HBV Infection: HBV Cure. Viruses 2022; 14(4): 657 doi: 10.3390/v14040657
|